Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1346676.RAQrS6nPT5bRfjVWrr268eaGQbwODs9DrfnpLYhhCm4U4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1346676.RAQrS6nPT5bRfjVWrr268eaGQbwODs9DrfnpLYhhCm4U4130_assertion type Assertion NP1346676.RAQrS6nPT5bRfjVWrr268eaGQbwODs9DrfnpLYhhCm4U4130_head.
- NP1346676.RAQrS6nPT5bRfjVWrr268eaGQbwODs9DrfnpLYhhCm4U4130_assertion description "[The amplification rate of C-myc, C-N-ras, C-Ki-ras and C-erbB-2 in ovarian carcinoma were 50%, 44%, 31% and 25% respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1346676.RAQrS6nPT5bRfjVWrr268eaGQbwODs9DrfnpLYhhCm4U4130_provenance.
- NP1346676.RAQrS6nPT5bRfjVWrr268eaGQbwODs9DrfnpLYhhCm4U4130_assertion evidence source_evidence_literature NP1346676.RAQrS6nPT5bRfjVWrr268eaGQbwODs9DrfnpLYhhCm4U4130_provenance.
- NP1346676.RAQrS6nPT5bRfjVWrr268eaGQbwODs9DrfnpLYhhCm4U4130_assertion SIO_000772 8585978 NP1346676.RAQrS6nPT5bRfjVWrr268eaGQbwODs9DrfnpLYhhCm4U4130_provenance.
- NP1346676.RAQrS6nPT5bRfjVWrr268eaGQbwODs9DrfnpLYhhCm4U4130_assertion wasDerivedFrom befree-2016 NP1346676.RAQrS6nPT5bRfjVWrr268eaGQbwODs9DrfnpLYhhCm4U4130_provenance.
- NP1346676.RAQrS6nPT5bRfjVWrr268eaGQbwODs9DrfnpLYhhCm4U4130_assertion wasGeneratedBy ECO_0000203 NP1346676.RAQrS6nPT5bRfjVWrr268eaGQbwODs9DrfnpLYhhCm4U4130_provenance.